Literature DB >> 29294127

Efficacy of guanidinoacetic acid on growth and muscle energy metabolism in broiler chicks receiving arginine-deficient diets.

A A DeGroot1, U Braun2, R N Dilger1.   

Abstract

Guanidinoacetic acid (GAA) is formed from arginine (Arg) and is the immediate precursor to creatine (Cr) and phosphocreatine (PCr), which are important compounds involved in muscle energy homeostasis. This study sought to determine whether GAA could spare Arg in broiler chicks fed an Arg-deficient practical diet. A basal [0.84% standardized ileal digestible (SID) Arg] was supplemented with combinations of L-Arg (0 or 0.16%) and GAA (0, 0.06, or 0.12%) to form a factorial arrangement of diets; the unsupplemented basal served as the negative control (NC). Additionally, the basal was supplemented with 0.32% Arg to generate an Arg-adequate positive control (PC). Mash diets were fed to 8 replicate pens of 5 chicks per treatment from d 8 to 22 posthatch, with measurements including growth performance, blood GAA metabolites, muscle cellular energy markers, and clinical outcomes. Supplementation of 0.16% Arg increased (P < 0.05) BW gain from d 15 to 22 posthatch, while graded addition of GAA tended to improve BW gain (P < 0.094). Supplementation of either Arg or GAA increased (P < 0.05) feed efficiency from d 15 to 22 and d 8 to 22 posthatch. Birds fed the PC diet had greater (P < 0.05) responses for nearly all blood and tissue outcomes compared with NC-fed birds. Serum GAA was more responsive to supplementation of GAA in the presence versus absence of supplemental Arg (interaction, P < 0.001). Interactions (P < 0.05) were also observed for concentrations of muscle total Cr, creatinine, and most serum essential amino acids, notably Arg. Serum Cr, as well as muscle PCr, total Cr, and glycogen were increased (P < 0.05) independently by Arg and GAA supplementation, with highest levels achieved via combined addition of 0.12% GAA and 0.16% Arg. Minimal effects were detected on hematological and clinical chemistry outcomes. Overall, we conclude that GAA supplementation can spare Arg in broiler chicks fed Arg-deficient practical diets as evidenced by improvements in growth performance and muscle energy stores.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29294127     DOI: 10.3382/ps/pex378

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  6 in total

1.  Guanidine acetic acid supplementation altered plasma and tissue free amino acid profiles in finishing pigs.

Authors:  Yiyan Cui; Zhimei Tian; Miao Yu; Dun Deng; Huijie Lu; Min Song; Xianyong Ma; Limin Wang
Journal:  Porcine Health Manag       Date:  2022-06-07

2.  Relative bioavailability of guanidinoacetic acid delivered ruminally or abomasally to cattle.

Authors:  Hannah F Speer; Kimberly A Pearl; Evan C Titgemeyer
Journal:  J Anim Sci       Date:  2020-09-01       Impact factor: 3.159

3.  Guanidinoacetic acid is efficacious in improving growth performance and muscle energy homeostasis in broiler chicks fed arginine-deficient or arginine-adequate diets.

Authors:  A A DeGroot; U Braun; R N Dilger
Journal:  Poult Sci       Date:  2019-07-01       Impact factor: 3.352

4.  From broiler breeder hen feed to the egg and embryo: The molecular effects of guanidinoacetate supplementation on creatine transport and synthesis.

Authors:  Naama Reicher; Tomer Epstein; Dor Gravitz; Avigdor Cahaner; Meike Rademacher; Ulrike Braun; Zehava Uni
Journal:  Poult Sci       Date:  2020-04-25       Impact factor: 3.352

5.  Response of laying hens to l-arginine, l-citrulline and guanidinoacetic acid supplementation in reduced protein diet.

Authors:  Hiep Thi Dao; Nishchal K Sharma; Emma J Bradbury; Robert A Swick
Journal:  Anim Nutr       Date:  2021-03-12

6.  Guanidinoacetic acid supplementation improves feed conversion in broilers subjected to heat stress associated with muscle creatine loading and arginine sparing.

Authors:  M Majdeddin; U Braun; A Lemme; A Golian; H Kermanshahi; S De Smet; J Michiels
Journal:  Poult Sci       Date:  2020-06-20       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.